Arctic Monkeys and War Child Records have unveiled "Opening Night," the lead single to the upcoming charity compilation ...

Akebia Therapeutics is refocusing on Vafseo for dialysis patients, discontinuing expansion to non-dialysis, which has reset ...

What they've accomplished so far: The Rays have traded major players -- Shane Baz, Brandon Lowe, and Jake Mangum -- in two ...

ETFs offer a convenient way for investors to gain broad, diversified exposure to stocks. It's hard to beat Vanguard's S&P 500 ETF, which has delivered excellent results over time. Vanguard's ...

(RTTNews) - Biotechnology company Q32 Bio, Inc. (QTTB) announced Monday it has sold its Phase 2 complement inhibitor, ADX-097, to Akebia Therapeutics, Inc. (AKBA). ADX-097, the lead product candidate ...

-- $12 million in upfront and guaranteed near-term milestone payments expected to extend cash runway into the second half of 2027 -- -- Eligible to receive up to a total of $592 million including the ...

Daniel is a News Writer from the United Kingdom. Relatively new to the industry with almost three years of experience, he has focused on establishing himself in the gaming space. While he focuses on ...

It had taken Bungie seven years of trial and error to land on systems for loot, leveling, investment and currency in Destiny 2 that were somewhat balanced and ...

DECATUR, Ill. (WAND) — A new addition to a Decatur park offers an opportunity for cycling growth among young people. The Decatur Park District announced the opening of a brand new bicycle skills ...

Over the last few seasons, the tight end position has become a lot more fantasy relevant, and Week 1 sees that trend continuing. On the week. 16 tight ends scored double-digit fantasy points in ...

When it comes to the Los Angeles Dodgers, few players are as consistent as catcher Will Smith. Originally drafted by the team in the first round of 2016 before making his debut in 2019, Smith has ...

SEOUL, South Korea--(BUSINESS WIRE)--ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared ...